FOR IMMEDIATE RELEASE (PDF DOWNLOAD) -NTS Exercises Option after Conducting Preclinical Research on Neuroactive Small Molecule ATLANTA, Ga., December 11, 2019 – – NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, and Emory University (Emory), a...

FOR IMMEDIATE RELEASE (PDF DOWNLOAD) Exosomes demonstrate ability to enhance anti-tumor effect of platinum-based drugs and to ameliorate peripheral neuropathy ATLANTA and DETROIT, April 26, 2019 – NeurExo Sciences, LLC (NXS), a biotechnology company...

FOR IMMEDIATE RELEASE ATLANTA and DETROIT, April 22, 2019 – NeurExo Sciences, LLC (NXS), a subsidiary of NeuroTrauma Sciences, LLC, and biotechnology company focused on the development of exosome therapies, and Henry Ford Health System (HFHS), a non-profit...

Dr. Michael Chopp to Highlight Advances in Stroke at Exosome Teach-In Event in New York on February 12th ATLANTA, DETROIT and HONOLULU, January 31, 2019 – NeurExo Sciences, LLC (NXS), a biotechnology company focused on the development of exosome therapies,...

Research indicates exosomes have therapeutic potential for improving recovery after stroke, traumatic brain injury ATLANTA and DETROIT, January 23, 2019 – NeurExo Sciences, LLC (NXS), a biopharmaceutical company and subsidiary of NeuroTrauma Sciences, LLC, will be...

Research indicates exosomes have therapeutic potential for improving recovery after stroke, traumatic brain injury   ATLANTA and DETROIT, July 16, 2018 – NeuroTrauma Sciences, LLC (NTS), a biopharmaceutical company, and Henry Ford Health System, a...